Hospital

Ochsner partners with Latent Health to utilize clinical artificial intelligence (AI), speeding prior authorizations, improving pharmacy efficiency, and increasing patient access to medications.

UPMC Health Plan enhances COPD care through personalized treatment, telemedicine, and comprehensive support, ensuring optimal patient outcomes and adherence.

Cephalosporins are commonly prescribed in the outpatient setting; understanding differences among them is important for pharmacists.

Trastuzumab deruxtecan shows promising efficacy in treating HER2-positive metastatic breast cancer with brain metastases, offering hope for challenging cases.

The decentralization of US health care, accelerated by virtual care adoption, shifting reimbursement models, and a growing demand for complex therapies, is elevating the role of specialty and infusion pharmacies as essential, tech-enabled partners in delivering coordinated, patient-centered care across outpatient and home-based settings.

Finerenone plays an emerging role in managing complex heart failure with preserved ejection fraction (HFpEF).

Immense burden is laid upon patients with cancer who are infected with COVID-19, as they are at higher risk of experiencing cancer treatment disruptions and severe illness that necessitates hospitalization.

Eugene Przespolewski, PharmD, BCOP, DPLA, shares insights from his presentation at the 2025 OPC meeting in Austin, Texas.

New research reveals uranium isotopes in urine as potential biomarkers for kidney damage, highlighting risks from contaminated drinking water in the US.

Carrie Harney, JD, of US Pharmacopeia (USP) discusses how proposed tariffs could impact generic drug supply chains, sterile injectable shortages, and pharmacy operations, underscoring the need for policy incentives and manufacturing diversification.

UPMC Health Plan enhances COPD care through a multidisciplinary approach, leveraging telehealth, education, and pharmacist-led programs to optimize patient outcomes.

Results from the ZENITH trial show sotatercept's promise for pulmonary arterial hypertension treatment.

Omolola (Lola) A. Adeoye-Olatunde, PharmD, MS, discusses her passion for advancing community-engaged pharmacy research.

Critically ill patients treated with a pharmacist-managed insulin protocol achieved higher rates of glucose control than those treated with conventional methods.

Pharmacists play a critical role in preventing medication ordering errors during residency onboarding through proactive training, system safeguards, and interdisciplinary collaboration.

Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.

The advisory committee cited concerns around ocular toxicity and overall tolerability, raising serious questions about the drug's benefit-risk profile ahead of its scheduled Prescription Drug User Fee Act action date on July 23, 2025.

Researchers unveil a groundbreaking method using polypurine hairpins to inhibit PCSK9, offering a promising alternative for lowering cholesterol and reducing cardiovascular risk.

Immunocompromised patients, especially transplant recipients, face heightened RSV risks, leading to severe infections and complications.

The National Comprehensive Cancer Network (NCCN) has released multiple myeloma guidelines version 2.2026 to include linvoseltamab as a preferred treatment for heavily pretreated patients, highlighting its intravenous formulation, dosing options, and streamlined Risk Evaluation and Mitigation Strategy program.

NCCN updates ovarian cancer guidelines, emphasizing personalized maintenance therapy with niraparib for HR-deficient patients, enhancing oncology pharmacists' roles.

GLP-1 compounding faces legal challenges, evolving FDA rules, and heightened enforcement risks.

UPMC's integrated approach to COPD care enhances patient outcomes through personalized support, coordinated services, and effective pulmonary rehabilitation strategies.

Once-weekly efsitora alfa shows promising hemoglobin A1C reduction in type 2 diabetes (T2D), simplifying insulin therapy and reducing injection frequency significantly.

Research reveals HER2-negative breast cancer shows higher pCR rates than HER2-low, influencing neoadjuvant chemotherapy strategies for early-stage patients.

Research reveals that higher BMI in women with cardiovascular disease significantly increases breast cancer risk, highlighting the need for targeted prevention strategies.

The FDA approves a prefilled syringe for the zoster vaccine recombinant, enhancing shingles vaccination convenience and effectiveness for adults 50 years and older.